Recent Updates
Recently added Catalysts
NATR

Fourth Quarter 2016 Financial Highlights

Key Takeaway: NATURE'S SUNSHINE PRODUCTS REPORTS FOURTH QUARTER 2016 FINANCIAL RESULTS LEHI, Utah, March 7, 2017 - Nature's Sunshine Products, Inc. (NASDAQ: NATR), a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care prod

Full Press Release Details

NATURE'S SUNSHINE PRODUCTS REPORTS FOURTH QUARTER 2016 FINANCIAL RESULTS
LEHI, Utah, March 7, 2017 - Nature's Sunshine Products, Inc. (NASDAQ: NATR), a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care products, today reported its financial results for the fourth quarter ended December 31, 2016.
Fourth Quarter 2016 Financial Highlights
Full Year 2016 Financial Highlights
Management Commentary
"Fourth quarter financial results were negatively impacted by items related to delay and uncertainty surrounding receipt of a direct selling license in China" commented Gregory L. Probert, Chairman and Chief Executive Officer. "While our 2016 financial results have been constrained by the infrastructure built in anticipation of a future market opportunity, we remain steadfast in our belief that the investments are prudent given the potential opportunity that lies ahead of us should the regulatory process in China be completed."
Mr. Probert continued, "We continued to post modest growth in NSP North America during the fourth quarter and Synergy Worldwide again enjoyed good momentum in Synergy Asia Pacific. During 2016, we introduced the Elite Health program in Synergy Asia Pacific and Synergy Europe, and continued to promote our patent-pending IN.FORM program in NSP North America. We look to leverage these new product initiatives to drive further growth and support our new market investments."
Fourth Quarter 2016 Regional Sales by Operating Segment
Net Sales by Operating Segment
Three Months Ended December 31, 2016 Three Months Ended December 31, 2015 Percent Change Impact of Currency Exchange Percent Change Excluding Impact of Currency
NSP Americas:
NSP North America $ 35,824 $ 35,656 0.5 % $ (8 ) 0.5 %
NSP Latin America 6,930 7,452 (7.0 ) % (109 ) (5.5 ) %
42,754 43,108 (0.8 ) % (117 ) (0.5 ) %
NSP Russia, Central and Eastern Europe $ 6,929 $ 6,829 1.5 % $ (42 ) 2.1 %
Synergy WorldWide:
Synergy Asia Pacific 22,844 20,100 13.7 % 506 11.1 %
Synergy Europe 5,227 6,359 (17.8 ) % (93 ) (16.3 ) %
Synergy North America 2,530 2,577 (1.8 ) % - (1.8 ) %
30,601 29,036 5.4 % 413 4.0 %
China and New Markets $ 3,666 $ 1,021 259.1 % $ - 259.1 %
$ 83,950 $ 79,994 4.9 % $ 254 4.6 %
Fiscal Year 2016 Regional Sales by Operating Segment
Net Sales by Operating Segment
2016 2015 Percent Change Impact of Currency Exchange Percent Change Excluding Impact of Currency
NSP Americas:
NSP North America $ 148,048 $ 147,017 0.7 % $ (404 ) ) 1.0 %
NSP Latin America 27,874 32,134 (13.3 ) % (1,550 ) ) (8.4 ) %
175,922 179,151 (1.8 ) % (1,954 ) ) (0.7 ) %
NSP Russia, Central and Eastern Europe $ 25,971 $ 27,408 (5.2 ) % $ (163 ) ) (4.6 ) %
Synergy WorldWide:
Synergy Asia Pacific 89,694 76,479 17.3 % (229 ) ) 17.6 %
Synergy Europe 24,328 25,829 (5.8 ) % (68 ) ) (5.5 ) %
Synergy North America 10,771 11,773 (8.5 ) % - (8.5 ) %
124,793 114,081 9.4 % (297 ) ) 9.7 %
China and New Markets $ 14,473 $ 4,065 256.0 % $ - 256.0 %
$ 341,159 $ 324,705 5.1 % $ (2,414 ) ) 5.8 %
Active Distributors and Customers by Segment (1)
2016 2015
Distributors & Customers Managers Distributors & Customers Managers
NSP Americas 121,200 6,400 131,600 6,500
NSP Russia, Central and Eastern Europe 66,700 2,800 72,000 2,800
Synergy WorldWide 53,600 3,700 60,800 3,400
China and New Markets 2,100 - - -
Total 243,600 12,900 264,400 12,700
Cash Flow and Balance Sheet Highlights
Nature's Sunshine Products will host a conference call to discuss its fourth quarter 2016 results on March 7, 2017 at 4:30 PM Eastern Time. The toll-free dial-in number for callers in the U.S. and Canada is 1-877-423-9813, conference ID: 13656293. International callers can dial 1-201-689-8573, conference ID: 13656293. A replay will be available from March 7, 2017 at 7:30 PM Eastern Time through March 21, 2017 at 11:59 PM Eastern Time by dialing 1-844-512-2921 (U.S. and Canada) or 1-412-317-6671 (International), replay PIN: 13656293. The call will also be webcast live and will be available on the Investors section of Nature's Sunshine Products' website at www.naturessunshine.com for 90 days.
About Nature's Sunshine Products
Nature's Sunshine Products (NASDAQ: NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products through a global direct sales force of approximately 550,000 independent Managers, Distributors and customers in more than 40 countries. Nature's Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety and efficacy on the market today. The Company has four reportable business segments that are divided based on the characteristics of their Distributor base, similarities in compensation plans, as well as the internal organization of NSP's officers and their responsibilities (NSP Americas; NSP Russia, Central and Eastern Europe; Synergy WorldWide; and China and New Markets). The Company also supports health and wellness for children around the world through its partnership with the Sunshine Heroes Foundation. Additional information about the Company can be obtained at its website,
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements regarding the Company's future business expectations, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to the Company's objectives, plans and strategies. All statements (other than statements of historical fact) that address activities, events or developments that the Company intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as "believe," "hope," "may," "anticipate," "should," "intend," "plan," "will," "expect," "estimate," "project," "positioned," "strategy" and similar expressions, and are based on assumptions and assessments made by management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, including the following.
These and other risks and uncertainties that could cause actual results to differ from predicted results are more fully detailed under the caption "Risk Factors" in our reports filed with the the Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports filed on Forms 10-Q.
All forward-looking statements speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in or incorporated by reference into this press release. Except as is required by law, the Company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this press release.
Non-GAAP Financial Measures
The Company has included information which has not been prepared in accordance with generally accepted accounting principles (GAAP), such as information concerning Adjusted EBITDA and net sales excluding the impact of foreign currency exchange fluctuations. Management utilizes the non-GAAP measure Adjusted EBITDA in the evaluation of its operations and believes that this measure is a useful indicator of the Company's ability to fund its business. This non-GAAP financial measure should not be considered as an alternative to, or more meaningful than, U.S. GAAP net income as an indicator of the Company's operating performance. Moreover, Adjusted EBITDA, as presented by the Company, may not be comparable to similarly titled measures reported by other companies.
In addition, the Company believes presenting the impact of foreign currency fluctuations is useful to investors because it allows a more meaningful comparison of net sales of its foreign operations from period to period. Net sales excluding the impact of foreign currency fluctuations should not be considered in isolation or as an alternative to net sales in U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP.
Other companies may use the same or similarly named measures, but exclude different items, which may not provide investors with a comparable view of Nature's Sunshine Products' performance in relation to other companies. The Company has included a reconciliation of Adjusted EBITDA to net income/loss, the most comparable GAAP measure, in the attached financial tables.
NATURE'S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands, except per share information)
Three Months Ended December 31, 2016 2015
Net sales $ 83,950 $ 79,994
Cost of sales (24,327 ) (21,753 )
Gross profit 59,623 58,241
Operating expenses:
Volume incentives 29,558 29,156
Selling, general and administrative 31,452 26,865
Operating income (loss) (1,387 ) 2,220
Other expense: (1,730 ) (25 )
Income (loss) from continuing operations before provision for income taxes (3,117 ) 2,195
Provision (benefit) for income taxes 4,305 (1,140 )
Net income (loss) (7,422 ) 3,335
Net loss attributable to noncontrolling interests (769 ) (358 )
Net income (loss) attributable to common shareholders $ (6,653 ) $ 3,693
Basic and diluted net income per common share
Basic earnings (loss) per share attributable to common shareholders:
Net income (loss) attributable to common shareholders $ (0.35 ) $ 0.20
Diluted earnings (loss) per share attributable to common shareholders:
Net income (loss) attributable to common shareholders $ (0.35 ) $ 0.19
Weighted average basic common shares outstanding 18,755 18,591
Weighted average diluted common shares outstanding 18,755 19,023
Dividends declared per common share $ 0.10 $ 0.10
NATURE'S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands, except per share information)
Year Ended December 31, 2016 2015
Net sales $ 341,159 $ 324,705
Cost of sales (90,937 ) (85,345 )
Gross profit 250,222 239,360
Operating expenses:
Volume incentives 119,910 117,786
Selling, general and administrative 120,273 107,702
Operating income 10,039 13,872
Other expense (773 ) (592 )
Income from continuing operations before provision for income taxes 9,266 13,280
Provision for income taxes 8,591 1,740
Net income from continuing operations 675 11,540
Income from discontinued operations - 2,116
Net income 675 13,656
Net loss attributable to noncontrolling interests (1,464 ) (1,031 )
Net income attributable to common shareholders $ 2,139 $ 14,687
Basic and diluted net income per common share
Basic earnings per share attributable to common shareholders:
Net income from continuing operations $ 0.11 $ 0.67
Income from discontinued operations $ - $ 0.11
Net income attributable to common shareholders $ 0.11 $ 0.79
Diluted earnings per share attributable to common shareholders:
Net income from continuing operations $ 0.11 $ 0.66
Income from discontinued operations $ - $ 0.11
Net income attributable to common shareholders $ 0.11 $ 0.77
Weighted average basic common shares outstanding 18,731 18,656
Weighted average diluted common shares outstanding 19,056 19,177
Dividends declared per common share $ 0.40 $ 0.40
NATURE'S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands)
As of December 31, 2016 2015
Assets
Current assets:
Cash and cash equivalents $ 32,284 $ 41,420
Accounts receivable, net of allowance for doubtful accounts of $205 and $190, respectively 7,738 7,700
Investments available for sale 1,776 1,772
Assets held for sale 521 -
Inventories 47,597 38,495
Deferred income tax assets 5,620 5,021
Prepaid expenses and other 4,585 7,110
Total current assets 100,121 101,518
Property, plant and equipment, net 73,272 68,728
Investment securities - trading 1,391 1,044
Intangible assets, net 976 559
Deferred income tax assets 15,970 17,339
Other assets 13,840 11,332
$ 205,570 $ 200,520
Liabilities and Shareholders' Equity
Current liabilities:
Accounts payable $ 5,305 $ 6,341
Accrued volume incentives and service fees 16,264 14,913
Accrued liabilities 24,400 23,726
Deferred revenue 3,672 4,160
Revolving credit facility 9,919 2,696
Income taxes payable 3,475 1,300
Total current liabilities 63,035 53,136
Liability related to unrecognized tax benefits 6,755 7,809
Deferred compensation payable 1,391 1,044
Other liabilities 1,991 2,266
Total liabilities 73,172 64,255
Shareholders' equity:
Common stock, no par value; 50,000 shares authorized, 18,757 and 18,588 shares issued and outstanding as of December 31, 2016, and 2015, respectively 129,654 126,670
Retained earnings 12,718 18,088
Noncontrolling interests 1,286 2,750
Accumulated other comprehensive loss (11,260 ) (11,243 )
Total shareholders' equity 132,398 136,265
$ 205,570 $ 200,520
NATURE'S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
Year Ended December 31, 2016 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income $ 675 $ 13,656
Adjustments to reconcile net income to net cash provided by operating activities:
Impairment of property, plant and equipment, net 221 -
Provision for doubtful accounts 305 21
Depreciation and amortization 4,808 4,525
Share-based compensation expense 3,217 4,485
(Gain) loss on sale of property and equipment 149 (2,703 )
Deferred income taxes 766 (3,373 )
Purchase of trading investment securities (429 ) (252 )
Proceeds from sale of trading investment securities 147 239
Realized and unrealized gains on investments (63 ) (470 )
Foreign exchange losses 1,348 1,948
Changes in assets and liabilities:
Accounts receivable (343 ) (1,091 )
Inventories (9,569 ) 933
Prepaid expenses and other 2,442 636
Other assets (3,025 ) (4,010 )
Accounts payable (935 ) 593
Accrued volume incentives and service fees 1,477 (1,427 )
Accrued liabilities 1,519 (3,451 )
Deferred revenue (488 ) (557 )
Income taxes payable 1,924 (914 )
Liability related to unrecognized tax positions (1,076 ) 1,368
Deferred compensation payable 347 6
Net cash provided by operating activities 3,417 10,162
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment (11,028 ) (22,527 )
Proceeds from sale of property, plant and equipment - 3,128
Purchases of investments available for sale - (3 )
Proceeds from sale/maturities of investments available for sale 5 810
Purchase of intangible assets (509 ) -
Net cash used in investing activities (11,532 ) (18,592 )
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments of cash dividends (7,509 ) (7,490 )
Net borrowings on revolving credit facility 7,223 2,696
Proceeds from exercise of stock options - 3,861
Repurchase of common stock - (6,645 )
Net cash used in financing activities (286 ) (7,578 )
Effect of exchange rates on cash and cash equivalents (735 ) (1,271 )
Net decrease in cash and cash equivalents (9,136 ) (17,279 )
Cash and cash equivalents at beginning of the year 41,420 58,699
Cash and cash equivalents at end of the year $ 32,284 $ 41,420
NATURE'S SUNSHINE PRODUCTS, INC. AND SUBSIDIARIES
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA
(Amounts in thousands)
Three Months Ended December 31, 2016 2015
Net income (loss) from continuing operations $ (7,422 ) $ 3,335
Adjustments:
Depreciation and amortization 1,198 1,200
Share-based compensation expense 805 1,209
Other loss, net* 1,730 25
Provision (benefit) for income taxes 4,305 (1,140 )
Adjusted EBITDA $ 616 $ 4,629
Year Ended December 31, 2016 2015
Net income from continuing operations $ 675 $ 11,540
Adjustments:
Depreciation and amortization 4,808 4,525
Share-based compensation expense 3,217 4,485
Other loss, net* 773 592
Provision for income taxes 8,591 1,740
Adjusted EBITDA $ 18,064 $ 22,882
* Other income (loss), net is primarily comprised of foreign exchange gains (losses), interest income, and interest expense.
Last updated: Mar 7, 2017